Highlights Telix Pharmaceuticals Limited

Equities

TLX

AU000000TLX2

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 07:10:02 15/05/2026 BST			5-day change	1st Jan Change
14.72 ^AUD	-0.88%		-0.20%	+31.43%

05-15	Telix to Collaborate With EDAP, Profound Medical to Explore PSMA-PET Imaging in Prostate Cancer Therapies	MT
05-15	Telix announces collaborations to explore PSMA-PET imaging in emerging prostate cancer treatment approaches	RE

Highlights

05-15	Telix Pharmaceuticals Limited, EDAP TMS S.A., Profound Medical Corp. Enter Strategic Collaboration To Explore PSMA-PET Imaging In Prostate Cancer Treatment	CI
05-14	EDAP TMS S.A. and Telix Pharmaceuticals Limited Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer	CI
05-04	Telix Pharmaceuticals Limited Announces New Analysis of Tlx250-Px Phase 3 Zircon Trial Data	CI
05-01	Telix Pharmaceuticals says TLX101-PX (Pixlumi®) MAA accepted in Europe	RE
05-01	Telix Pharmaceuticals Limited Announces Acceptance Of Marketing Authorization Application For TLX101-Px In Europe	CI
05-01	Telix Says Marketing Authorization Application for Glioma Imaging Candidate Accepted for Review in Europe; Shares Up 3%	MT
04-29	Telix Pharmaceuticals Limited Presents Initial Dosimetry Data For TLX597-Tx In Prostate Cancer	CI
04-23	Telix Pharmaceuticals Settles Issue of $600 Million Convertible Notes	MT
04-23	Telix Pharmaceuticals announces settlement of $600m convertible bonds	RE
04-17	Telix Pharmaceuticals Says JPMorgan Increases Stake	MT
04-15	Telix Pharmaceuticals Limited Doses First Patient in Phase 3 Ipax-Bright Trial of Tlx101-Tx for Recurrent Glioblastoma	CI
04-15	Telix Pharmaceuticals Upsizes Convertible Notes Due 2031 to $600 Million	MT
04-13	Regeneron Pharmaceuticals, Inc. and Telix Pharmaceuticals Limited Announce Strategic Radiopharma Collaboration	CI
04-13	Telix Pharmaceuticals' Pipeline Validated by Regeneron Deal, Citi Says	MT
04-13	Telix and Regeneron announce radiopharma collaboration	RE
04-13	Telix Pharmaceuticals, Regeneron Form Radiopharmaceutical Partnership	MT
04-10	Telix Pharmaceuticals Limited Announces FDA Acceptance Of Resubmitted New Drug Application For TLX101-Px1 (Pixclara®)	CI
04-10	Telix Pharmaceuticals Says US FDA Accepts New Drug Application for Brain Cancer Imaging Agent	MT
04-07	Telix Pharmaceuticals US PSMA PET Sales Gain Traction, Seen to Grow Market Share, Says Jefferies	MT
04-07	Telix Pharmaceuticals Q1 Revenue Rises; Full-Year Sales Outlook Reaffirmed -- Shares Up Pre-Bell	MT
04-07	Telix Pharmaceuticals Limited Reaffirms Earnings Guidance for the Fiscal Year 2026	CI
04-07	Telix pharmaceuticals posts Q1 2026 unaudited group revenue of US$230 million	RE
04-07	Telix Pharmaceuticals Q1 Revenue Rises 24%; Shares Gain 6%	MT
03-20	Telix Pharmaceuticals Says Citigroup Lifts Stake	MT
03-16	Telix Pharmaceuticals Refiles NDA for Brain Cancer Imaging Candidate	MT